Foot News and Research

RSS

Onyx announces data from regorafenib Phase 3 trial on GIST

Onyx Pharmaceuticals today announced data from the Phase 3 GRID (GIST – Regorafenib In Progressive Disease) trial evaluating the investigational drug regorafenib, a Bayer compound, in patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease had progressed despite prior treatment with imatinib and sunitinib.

4 Jun 2012

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced results from the trastuzumab emtansine Phase III EMILIA trial conducted by Roche.

4 Jun 2012

HealthSouth to build comprehensive physical rehabilitation hospital in greater Orlando

HealthSouth Corporation today announced it has received permission from the state to proceed with building a comprehensive physical rehabilitation hospital in the greater Orlando, Fla., market. The 50-bed hospital will provide comprehensive physical rehabilitation to patients who have experienced stroke, trauma, brain and orthopedic injuries or other major illness or injuries.

2 Jun 2012

FDA approves RBI’s AppliGel-G for human testing

Royer Biomedical, Inc. (RBI) received FDA approval to proceed with Human Testing of AppliGel-G (Gentamicin) in management of Diabetic Foot Ulcers.

1 Jun 2012

State roundup: The effects of proposed Calif. budget cuts; Fewer free vaccinations in Texas

Low-income children in rural California communities are in jeopardy of losing their doctors and health care plans under Gov. Jerry Brown's budget proposal, state lawmakers, doctors and health advocates say. The governor is proposing to transfer nearly 900,000 children enrolled in Healthy Families, the state's Children's Health Insurance Program, to Medi-Cal – a program aimed at serving the state's poorest families, seniors and disabled residents.

30 May 2012

AHF's 'Condom-Nation' tour

“This tour is a national call to action to achieve these goals and we are delighted to be working with our three partner agencies in Chicago this weekend.”

28 May 2012

Clinilabs opens second Phase I unit in Southern New Jersey

Clinilabs, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, today announced that they have opened a second Phase I unit in Southern New Jersey.

28 May 2012

New medicine can start and hasten healing of diabetic and other chronic sores

A unique new medicine that can start and hasten healing of diabetic and other chronic sores is being developed at Umeå University in Sweden. After several years of successful experimental research, it is now ready for clinical testing.

28 May 2012

UCSF receives $20M Sandler Foundation gift for neuroscience research and care

UCSF has received a challenge gift of $20 million from the Sandler Foundation that will provide major support for the university's groundbreaking research and clinical care efforts regarding neurological diseases.

25 May 2012

PERK protein necessary to maintain behavioral flexibility

Researchers have identified a protein necessary to maintain behavioral flexibility, which allows us to modify our behaviors to adjust to circumstances that are similar, but not identical, to previous experiences. Their findings, which appear in the journal Cell Reports, may offer new insights into addressing autism and schizophrenia—afflictions marked by impaired behavioral flexibility.

25 May 2012

NYULMC opens new 327,000 square-foot Ambulatory Care Center

As part of its plan to expand access to a wide array of outpatient services, NYU Langone Medical Center has opened a new 327,000 square-foot Ambulatory Care Center (ACC) at 240 East 38th Street.

24 May 2012

Proper care of diabetic foot infections can save limbs, lives

Diabetic foot infections are an increasingly common problem, but proper care can save limbs and, ultimately, lives, suggest new guidelines released by the Infectious Diseases Society of America.

23 May 2012

Scientists determine genetic sequences of all 12 vancomycin-resistant staph strains

National Institutes of Health-funded scientists have determined the genetic sequences of all 12 available strains of Staphylococcus aureus bacteria resistant to vancomycin-an antibiotic of last resort-and have demonstrated that resistance arose independently in each strain after it acquired a specific bit of genetic material called transposon Tn1546

23 May 2012

More than 16,000 patients visit NYU Langone's new CMC

If the first month at NYU Langone's new Center for Musculoskeletal Care (CMC) is any indication of the growing need for integrated care, the more than 16,000 patients coming to the facility on 38th Street in Manhattan since it opened in April is a true testament.

22 May 2012

Poll: 70% of Americans oppose efforts by insurance companies to deny payment for ER visits

Seventy percent of Americans oppose efforts by insurance companies to deny payment for emergency visits when patients believe they are having medical emergencies, but after examination are diagnosed with non-urgent medical conditions, according to the results of a new poll conducted by Harris Interactive on behalf of the American College of Emergency Physicians.

21 May 2012

Experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes

For the first time, scientists at the Toronto General Hospital Research Institute have shown that an experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes.

21 May 2012

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society (APS), honored the recipients of its sixth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

19 May 2012

Damage to brain white matter connections may be the cause of Phineas Gage's behavioral changes

Poor Phineas Gage. In 1848, the supervisor for the Rutland and Burlington Railroad in Vermont was using a 13-pound, 3-foot-7-inch rod to pack blasting powder into a rock when he triggered an explosion that drove the rod through his left cheek and out of the top of his head. As reported at the time, the rod was later found, "smeared with blood and brains."

17 May 2012

Derma Sciences first quarter net sales increase 6% to $15.3 million

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three months ended March 31, 2012.

15 May 2012

InVivo Therapeutics reports net income of $3,150,000 for first quarter 2012

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported the financial results for the three months ended March 31, 2012 and provided a business update.

15 May 2012

Foot News and Research

Onyx announces data from regorafenib Phase 3 trial on GIST

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

HealthSouth to build comprehensive physical rehabilitation hospital in greater Orlando

FDA approves RBI’s AppliGel-G for human testing

State roundup: The effects of proposed Calif. budget cuts; Fewer free vaccinations in Texas

AHF's 'Condom-Nation' tour

Clinilabs opens second Phase I unit in Southern New Jersey

New medicine can start and hasten healing of diabetic and other chronic sores

UCSF receives $20M Sandler Foundation gift for neuroscience research and care

PERK protein necessary to maintain behavioral flexibility

NYULMC opens new 327,000 square-foot Ambulatory Care Center

Proper care of diabetic foot infections can save limbs, lives

Scientists determine genetic sequences of all 12 vancomycin-resistant staph strains

More than 16,000 patients visit NYU Langone's new CMC

Poll: 70% of Americans oppose efforts by insurance companies to deny payment for ER visits

Experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

Damage to brain white matter connections may be the cause of Phineas Gage's behavioral changes

Derma Sciences first quarter net sales increase 6% to $15.3 million

InVivo Therapeutics reports net income of $3,150,000 for first quarter 2012

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News